Imaging Recommendations for Diagnosis, Staging, and Management of Oral Cancer

Abstract

Oral cavity cancers contribute to a majority of cancers in India. Clinical examination alone cannot determine the deeper extent of the disease; therefore, need for cross-sectional imaging including computed tomography and magnetic resonance imaging becomes indispensable for pre-treatment evaluation to decide optimal plan of management. Oral cavity squamous cell cancers (OSCC) can be treated with surgery alone, whereas deep muscle, neurovascular, osseous, or nodal involvement on imaging suggests advanced disease that requires a combination of surgery, radiation, and/or chemotherapy. Because of the complex anatomy of the oral cavity and its surrounding structures, imaging is crucial for locoregional staging and early detection of distant metastases. Imaging plays indispensable role not only in diagnosis but also in planning the management. An optimal guideline paper for developing countries like India is lacking that not only helps standardize the management but will also assist oncologists make reasonable decisions and reduce the unnecessary imaging. This imaging guideline paper will discuss the optimal imaging in diagnosis and management OSCC for Indian subcontinent.

Keywords

computed tomography - guidelines - magnetic resonance imaging - oral cancer - imaging

The article is not under consideration for publication elsewhere. Each author participated sufficiently for the work to be submitted. Publication is approved by all authors.

Publication History

Article published online:
01 March 2023

• References

• 1 Starzyńska A, Sobocki BK, Alterio D. Current challenges in head and neck cancer management. Cancers (Basel) 2022; 14 (02) 358
• 2 Goel B, Tiwari AK, Pandey RK. et al. Therapeutic approaches for the treatment of head and neck squamous cell carcinoma-an update on clinical trials. Transl Oncol 2022; 21: 101426
• 3 Kato H, Matsuo M. Imaging findings of oral cancers. In Inflammation and Oral Cancer. Academic Press; 2022: 55-77
• 4 Asthana S, Labani S, Kailash U, Sinha DN, Mehrotra R. Association of smokeless tobacco use and oral cancer: a systematic global review and meta-analysis. Nicotine Tob Res 2019; 21 (09) 1162-1171
• 5 Epstein JB, Barasch A. Oral and dental health in head and neck cancer patients. In Multidisciplinary Care of the Head and Neck Cancer Patient. Springer, Cham; 2018: 43-57
• 6 Haider T, Yousaf Z, Khan AG, Fatima S. Awareness and practice of oral hygiene and its relation to socio-demographic factors among patients attending general OPD: Oral Hygiene & its Relation to Socio-Demographic Factors. Pakistan BioMedical Journal. 2022; 5 (02) 80-83
• 7 Woo SB. Oral epithelial dysplasia and premalignancy. Head Neck Pathol 2019; 13 (03) 423-439
• 8 Sarode G, Maniyar N, Sarode SC, Jafer M, Patil S, Awan KH. Epidemiologic aspects of oral cancer. Dis Mon 2020; 66 (12) 100988
• 9 Krishna Rao SV, Mejia G, Roberts-Thomson K, Logan R. Epidemiology of oral cancer in Asia in the past decade–an update (2000-2012). Asian Pac J Cancer Prev 2013; 14 (10) 5567-5577
• 10 Wong T, Yap T, Wiesenfeld D. Common benign and malignant oral mucosal disease. Aust J Gen Pract 2020; 49 (09) 568-573
• 11 Acharya B, Rayamajhi A. Imaging modalities in squamous cell carcinoma of head and neck: a review article. J Can Res Adv Ther. 2020; 1 (02) 19-23
• 12 Zanoni DK, Patel SG. New AJCC: how does it impact oral cancers?. Oral Oncol 2020; 104: 104607
• 13 Zanoni DK, Patel SG, Shah JP. Changes in the 8th edition of the American Joint Committee on Cancer (AJCC) staging of head and neck cancer: rationale and implications. Curr Oncol Rep 2019; 21 (06) 52
• 14 Grégoire V, Boisbouvier S, Giraud P, Maingon P, Pointreau Y, Vieillevigne L. Management and work-up procedures of patients with head and neck malignancies treated by radiation. Cancer Radiother 2022; 26 (1-2): 147-155
• 15 Borse V, Konwar AN, Buragohain P. Oral cancer diagnosis and perspectives in India. Sens Int 2020; 1: 100046
• 16 Yete S, D'Souza W, Saranath D. High-risk human papillomavirus in oral cancer: clinical implications. Oncology 2018; 94 (03) 133-141
• 17 D'Cruz AK, Vaish R, Dhar H. Oral cancers: current status. Oral Oncol 2018; 87: 64-69
• 18 Mahajan A, Ahuja A, Sable N, Stambuk HE. Imaging in oral cancers: a comprehensive review. Oral Oncol 2020; 104: 104658
• 19 Jeyaraj PR, Samuel Nadar ER. Computer-assisted medical image classification for early diagnosis of oral cancer employing deep learning algorithm. J Cancer Res Clin Oncol 2019; 145 (04) 829-837
• 20 Ilhan B, Lin K, Guneri P, Wilder-Smith P. Improving oral cancer outcomes with imaging and artificial intelligence. J Dent Res 2020; 99 (03) 241-248
• 21 Junn JC, Soderlund KA, Glastonbury CM. Imaging of head and neck cancer with CT, MRI, and US. In Seminars in Nuclear Medicine. WB Saunders: 2021. Jan 1 (Vol. 51, No. 1, pp. 3–12)
• 22 Murakami R, Shiraishi S, Yoshida R. et al. Reliability of MRI-derived depth of invasion of oral tongue cancer. Acad Radiol 2019; 26 (07) e180-e186
• 23 Maraghelli D, Pietragalla M, Calistri L. et al. Techniques, tricks, and stratagems of oral cavity computed tomography and magnetic resonance imaging. Appl Sci (Basel) 2022; 12 (03) 1473
• 24 Eneva MI, Nedevska M. MDCT amplified by the “puffed-cheek” maneuver in the radiological assessment of oral cavity tumors–a technical guide and a pictorial review of imaging findings. Vienna: European Congress of Radiology-ECR; 2018
• 25 Lee YC, Jung AR, Kwon OE. et al. Comparison of computed tomography, magnetic resonance imaging, and positron emission tomography and computed tomography for the evaluation bone invasion in upper and lower gingival cancers. J Oral Maxillofac Surg 2019; 77 (04) 875.e1-875.e9
• 26 Mahajan A, Dhone N, Vaish R. et al. Prognostic impact of pattern of mandibular involvement in gingivo-buccal complex squamous cell carcinomas: marrow and mandibular canal staging system. Front Oncol 2022; 11: 752018
• 27 Mao MH, Wang S, Feng ZE. et al. Accuracy of magnetic resonance imaging in evaluating the depth of invasion of tongue cancer. A prospective cohort study. Oral Oncol 2019; 91: 79-84
• 28 Aiken AH. Image-guided biopsies in the head and neck: practical value and approach. AJNR Am J Neuroradiol 2020; 41 (11) 2123-2125
• 29 Baulch J, Gandhi M, Sommerville J, Panizza B. 3T MRI evaluation of large nerve perineural spread of head and neck cancers. J Med Imaging Radiat Oncol 2015; 59 (05) 578-585
• 30 Hanna E, Vural E, Prokopakis E, Carrau R, Snyderman C, Weissman J. The sensitivity and specificity of high-resolution imaging in evaluating perineural spread of adenoid cystic carcinoma to the skull base. Arch Otolaryngol Head Neck Surg 2007; 133 (06) 541-545
• 31 Mahajan A, Smriti VM. Masseter pars coronoidea: Gateway between the masticator space and infratemporal fossa. Cancer Res Stat Treat 2022; 5 (01) 185
• 32 Mohiyuddin SMA, Harsha P, Maruvala S. et al. Outcome of compartment resection of locally advanced oral cancers extending to infratemporal fossa: a tertiary rural hospital experience. Eur Arch Otorhinolaryngol 2018; 275 (11) 2843-2850
• 33 Arya S, Chaukar D, Pai P. Imaging in oral cancers. Indian J Radiol Imaging 2012; 22 (03) 195-208
• 34 Liao CT, Ng SH, Chang JT. et al. T4b oral cavity cancer below the mandibular notch is resectable with a favorable outcome. Oral Oncol 2007; 43 (06) 570-579
• 35 Pantvaidya G, Rao K, D'Cruz A. Management of the neck in oral cancers. Oral Oncol 2020; 100: 104476
• 36 Abdel-Halim CN, Rosenberg T, Dyrvig AK. et al. Diagnostic accuracy of imaging modalities in detection of histopathological extranodal extension: A systematic review and meta-analysis. Oral Oncol 2021; 114: 105169
• 37 Irani S. Distant metastasis from oral cancer: A review and molecular biologic aspects. J Int Soc Prev Community Dent 2016; 6 (04) 265-271
• 38 Ishikawa S, Hiraka T, Kirii K. et al. Relationship between standard uptake values of positron emission tomography/computed tomography and salivary metabolites in oral cancer: a pilot study. J Clin Med 2020; 9 (12) 3958
• 39 Dhar H, Vaish R, D'Cruz AK. Management of locally advanced oral cancers. Oral Oncol 2020; 105: 104662
• 40 Geiger JL, Adelstein DJ. Chemotherapy in the definitive management of oral cancers: where do we stand today?. Oral Oncol 2020; 102: 104584
• 41 Strauss SB, Aiken AH, Lantos JE, Phillips CD. Best practices: application of NI-RADS for posttreatment surveillance imaging of head and neck cancer. AJR Am J Roentgenol 2021; 216 (06) 1438-1451
• 42 Dinkelborg P, Ro SR, Shnayien S. et al. Retrospective evaluation of NI-RADS for detecting postsurgical recurrence of oral squamous cell carcinoma on surveillance CT or MRI. AJR Am J Roentgenol 2021; 217 (01) 198-206
• 43 Jung AR, Roh JL, Kim JS, Choi SH, Nam SY, Kim SY. Post-treatment ¹⁸F-FDG PET/CT for predicting survival and recurrence in patients with advanced-stage head and neck cancer undergoing curative surgery. Oral Oncol 2020; 107: 104750
• 44 Koyfman SA, Ismaila N, Crook D. et al. Management of the neck in squamous cell carcinoma of the oral cavity and oropharynx: ASCO clinical practice guideline. J Clin Oncol 2019; 37 (20) 1753-1774
• 45 Bobdey S, Sathwara J, Jain A, Saoba S, Balasubramaniam G. Squamous cell carcinoma of buccal mucosa: an analysis of prognostic factors. South Asian J Cancer 2018; 7 (01) 49-54
• 46 Szturz P, Vermorken JB. Management of recurrent and metastatic oral cavity cancer: raising the bar a step higher. Oral Oncol 2020; 101: 104492
• 47 Swain M, Ghosh-Laskar S. Stereotactic body radiotherapy (SBRT) for primary non-metastatic head and neck cancer: when less is enough. Oral Oncol 2021; 116: 105265